ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $18,000 | +38.5% | 1,471 | +13.8% | 0.00% | – |
| Q1 2016 | $13,000 | -40.9% | 1,293 | +30.1% | 0.00% | – |
| Q4 2015 | $22,000 | +4.8% | 994 | -22.8% | 0.00% | – |
| Q3 2015 | $21,000 | +162.5% | 1,287 | +269.8% | 0.00% | – |
| Q2 2015 | $8,000 | +14.3% | 348 | +28.4% | 0.00% | – |
| Q1 2015 | $7,000 | +16.7% | 271 | +1.9% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 266 | -9.2% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 293 | -6.1% | 0.00% | – |
| Q2 2014 | $7,000 | – | 312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |